Home Products Antibodies Primary Antibodies 200085880
200085880

Novus Biologicals™ OX40/TNFRSF4 Antibody (cudarolimab) - Humanized, Novus Biologicals™

Human Monoclonal Antibody

Manufacturer: Fischer Scientific

The price for this product is unavailable. Please request a quote

Antigen

OX40/TNFRSF4

Applications

Flow Cytometry, ELISA, Functional Assay

Conjugate

Unconjugated

Host Species

Human

Research Discipline

Adaptive Immunity, B Cell Development and Differentiation Markers, Cancer, Cell Cycle and Replication, Immunology, Myeloid derived Suppressor Cell, Signal Transduction

Formulation

Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)

Gene Alias

ACT35 antigen, ACT35ATC35 antigen, CD134, CD134 antigen, OX40 cell surface antigen, OX40 homologue, OX40L receptor, OX40lymphoid activation antigene ACT35, TAX transcriptionally-activated glycoprotein 1 receptor, tax-transcriptionally activated glycoprotein 1 receptor, tumor necrosis factor receptor superfamily member 4, tumor necrosis factor receptor superfamily, member 4, TXGP1LOX40 antigen

Immunogen

TNFRSF4/ OX40/ CD134

Primary or Secondary

Primary

Reconstitution

Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.

Clone

cudarolimab

Classification

Monoclonal

Form

Purified

Regulatory Status

RUO

Target Species

Human

Gene Accession No.

P43489

Gene ID (Entrez)

7293

Isotype

IgG1

Purification Method

Protein A purified

Content And Storage

Store at -20°C in powder form. Store at -80°C once reconstituted.

Description

  • OX40/TNFRSF4 Monoclonal antibody specifically detects OX40/TNFRSF4 in Human samples
  • It is validated for Flow Cytometry,ELISA,Functional Assay